Willemijn R. Van Den Ancker

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Transcriptional profiling directs the classification of acute leukemias of ambiguous lineage into AML, B-ALL, or T-ALL.

Transcriptional profiling directs the classification of acute leukemias of ambiguous lineage into AML, B-ALL, or T-ALL.

Journal: HemaSphere
Published: November 04, 2024

Unfractionated heparin and the activated clotting time in non-cardiac arterial procedures.

Unfractionated heparin and the activated clotting time in non-cardiac arterial procedures.

Journal: The Journal of cardiovascular surgery
Published: May 31, 2023

De novo variants in CDK13 associated with syndromic ID/DD: Molecular and clinical delineation of 15 individuals and a further review.

De novo variants in CDK13 associated with syndromic ID/DD: Molecular and clinical delineation of 15 individuals and a further review.

Journal: Clinical genetics
Published: September 27, 2017

Direct sodium measurement prevents underestimation of hyponatremia in critically ill patients.

Direct sodium measurement prevents underestimation of hyponatremia in critically ill patients.

Journal: Intensive care medicine
Published: December 16, 2014

Class II-associated invariant chain peptide as predictive immune marker in minimal residual disease in acute myeloid leukemia.

Class II-associated invariant chain peptide as predictive immune marker in minimal residual disease in acute myeloid leukemia.

Journal: Oncoimmunology
Published: May 30, 2014

Procedures for the expansion of CD14(+) precursors from acute myeloid leukemic cells to facilitate dendritic cell-based immunotherapy.

Procedures for the expansion of CD14(+) precursors from acute myeloid leukemic cells to facilitate dendritic cell-based immunotherapy.

Journal: Immunotherapy
Published: November 06, 2013

High class II-associated invariant chain peptide expression on residual leukemic cells is associated with increased relapse risk in acute myeloid leukemia.

High class II-associated invariant chain peptide expression on residual leukemic cells is associated with increased relapse risk in acute myeloid leukemia.

Journal: Leukemia research
Published: October 25, 2013

Apoptotic blebs from leukemic cells as a preferred source of tumor-associated antigen for dendritic cell-based vaccines.

Apoptotic blebs from leukemic cells as a preferred source of tumor-associated antigen for dendritic cell-based vaccines.

Journal: Cancer immunology, immunotherapy : CII
Published: August 26, 2013

MicroRNA profiling can classify acute leukemias of ambiguous lineage as either acute myeloid leukemia or acute lymphoid leukemia.

MicroRNA profiling can classify acute leukemias of ambiguous lineage as either acute myeloid leukemia or acute lymphoid leukemia.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 28, 2013

Priming of PRAME- and WT1-specific CD8+ T cells in healthy donors but not in AML patients in complete remission: Implications for immunotherapy.

Priming of PRAME- and WT1-specific CD8+ T cells in healthy donors but not in AML patients in complete remission: Implications for immunotherapy.

Journal: Oncoimmunology
Published: November 17, 2012

A threshold of 10% for myeloperoxidase by flow cytometry is valid to classify acute leukemia of ambiguous and myeloid origin.

A threshold of 10% for myeloperoxidase by flow cytometry is valid to classify acute leukemia of ambiguous and myeloid origin.

Journal: Cytometry. Part B, Clinical cytometry
Published: May 30, 2012

Recent advances in antigen-loaded dendritic cell-based strategies for treatment of minimal residual disease in acute myeloid leukemia.

Recent advances in antigen-loaded dendritic cell-based strategies for treatment of minimal residual disease in acute myeloid leukemia.

Journal: Immunotherapy
Published: July 20, 2010
Showing 1-12 of 13

Last Updated: 09/26/2026